Gaurav Rajput, DO
Interventional Pain Medicine · Decatur, GANPI 1952656399
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (57.0%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Si-bone, Inc. at 28.8% of the total. Reporting peaked in 2019 at $6,583 and has fallen 73.8% since, to $1,726 in 2025.
Across 221 payments — averaging $66.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$4K
- Boston Scientific$3K
- Nevro Corp.$2K
- Medtronic$1K
- Forte Bio-pharma LLC$632
- Stryker$520
- plus $3K from 27 others
What the payments were for
- Consulting fees$1,83812%
- Travel & lodging$4,46030%
- Food & beverage$8,41557%
- Entertainment$470%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 21 | $4,258 |
| Boston Scientific | 22 | $2,675 |
| Nevro Corp. | 21 | $2,353 |
| Medtronic | 23 | $1,303 |
| Forte Bio-pharma LLC | 19 | $632 |
| Stryker | 7 | $520 |
| Spine Wave, Inc. | 6 | $418 |
| Collegium Pharmaceutical, Inc. | 24 | $414 |
| Curonix LLC | 11 | $389 |
| Spinal Simplicity, LLC | 5 | $311 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $251 |
| Painteq LLC | 2 | $209 |
| Foundation Fusion Solutions, LLC | 3 | $127 |
| Amgen(2 entities) | 8 | $125 |
| Johnson & Johnson | 1 | $111 |
| Zimmer Biomet | 1 | $110 |
| Abbott | 3 | $77 |
| Vertos Medical, Inc. | 1 | $62 |
| DJO, LLC | 1 | $62 |
| Spineology Inc. | 1 | $48 |
| Scilex Pharmaceuticals Inc. | 2 | $40 |
| Globus Medical | 1 | $35 |
| Baxter Healthcare | 2 | $34 |
| Providence Medical Technology, Inc. | 2 | $31 |
| Surgalign Spine Technologies, Inc. | 1 | $26 |
| USWM, LLC | 1 | $23 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Assertio Therapeutics, Inc. | 1 | $19 |
| Trevena, Inc. | 1 | $17 |
| Tenex Health Inc. | 1 | $16 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| Pfizer | 1 | $15 |
| SPR Therapeutics, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iFuse Implant$3,423
- Senza Spinal Cord Stimulation System$1,836
- Superion Indirect Decompression System$1,537
- Prolate$842
- INTELLIS ADAPTIVESTIM$745
- TANLOR$281
- Nalocet$281
- IFUSE IMPLANT SYSTEM$273
- OPTABLATE$245
- HA MINUTEMAN G3-R$234
- Spinal Implants$206
- WAVEWRITER ALPHA$150
- mild Device Kit$150
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$125
- RIGIDLOOP$111
- PAINTEQ$111
How this compares
$14,760 in reported general payments places this provider in the 80th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 124 | $74,511 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,617 | $50,695 |
| ProlateOxycodone Hcl/Acetaminophen | 20 | $44,263 |
| RelistorMethylnaltrexone Bromide | 15 | $40,392 |
| Buprenorphine | 139 | $37,054 |
| Nucynta ErTapentadol Hcl | 23 | $28,783 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,005 | $24,954 |
| Pregabalin | 653 | $10,950 |
| LyricaPregabalin | 14 | $10,851 |
| Xtampza ErOxycodone Myristate | 19 | $9,534 |
| Oxycodone Hcl | 403 | $6,640 |
| MovantikNaloxegol Oxalate | 12 | $5,619 |
| OxycontinOxycodone Hcl | 17 | $4,957 |
| Gabapentin | 381 | $4,461 |
| Lidocaine | 37 | $4,167 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er, Xtampza Er | $414 | $112,828166 claims |
| Forte Bio-pharma LLCProlate | $632 | $44,26320 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $251 | $40,39215 claims |
| PfizerLyrica | $15 | $10,85114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 129 interventional pain medicine providers in Georgia.
Other interventional pain medicine in Decatur
- Emmanuel GageBrunswick$602K
- Jordan TateJasper$540K
- Christopher BovinetBrunswick$338K
- David RosenfeldCovington$249K
- Nathan NeufeldNewnan$171K
- Ryan BudwanyLawrenceville$123K
- Alexandra MoreiraAtlanta$79K
- Sushanth BodaNewnan$55K
- Christopher AndrianoStockbridge$41K
- Guensley DelvaWaycross$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.